Therefore, we envisage a combination of CD133 and CD44 as a more reliable characterization of stem-like character, consistent with a notable report proposing CD133+ CD44+ cells isolated from Huh7 as bona fide cancer progenitor cells [24]. This evidence concerns the gene CD44 and cancer.